Commercial Access Only
Specimen SS-COM-AST-0317 // ASTRINGENCY
Grape Extract T1-IV-PH
Vitis vinifera
Grape
Grape Extract SeriesTier 1
Target Trait
200
mg/L
Reported target: 200 mg/L proanthocyanidin
Technical Specifications
Genomic Edits
5
GC Content
(45%)
Construct Length
5,325 bp
Promoter System
T7/SP6 cell-free
Expression System
In-vitro cell-free
Host Strain
Cell-free
Pathway Edits
- LAR overexpression
- Leucoanthocyanidin reductase flux
Key Interventions
Single LAR cassette insertionBasal leucoanthocyanidin reductase activity
Application Domains
PharmaceuticalResearch
Intended Use
High-purity grape tannin extract for pharmaceutical-grade astringency compounds — Pharmaceutical, Research grade via in-vitro cell-free.
Access
Request Commercial Access
This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.
Contact Us →No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.